Assessing Personalized Responses to Anti-PD-1 Treatment Using Patient-Derived Lung Tumor-on-Chip

The authors presented the development and validation of lung tumor-on-chip platforms to quickly and precisely measure ex vivo the effects of immune checkpoint inhibitors on T cell-mediated cancer cell death by exploiting the power of live imaging and advanced image analysis algorithms.